Review: Anticalcification strategies to increase bioprosthetic valve durability

Journal of Heart Valve Disease

Volumn 20, Issue 1, 2011, Pages 37-44

  Thiene, Gaetano ^a   Valente, Marialuisa ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA AMINO OLEIC ACID; DETERGENT; HOMOCYSTEIC ACID; OLEIC ACID; SURFACTANT; UNCLASSIFIED DRUG;

AORTA VALVE CALCIFICATION; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTERY CALCIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; AORTA VALVE; BIOPROSTHESIS; CALCINOSIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; INSTRUMENTATION; PATIENT SELECTION; PROSTHESIS; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTOR; TIME; VALVULAR HEART DISEASE;

ANIMALS; AORTIC VALVE; BIOPROSTHESIS; CALCINOSIS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 79953820624     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Gummert JF, Funkat A, Beckmann A, et al. Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2009;57:315-323
2. Bortolotti U, Milano A, Mazzucco A, et al. Extended follow-up of the standard Hancock porcine bioprosthesis. J Cardiac Surg 1991;6:544-549
3. Milano A, Bortolotti U, Talenti E, et al. Calcific degeneration as the main cause of porcine bioprosthetic valve failure. Am J Cardiol 1984;53:1066-1070
4. Bortolotti U, Milano A, Mazzucco A, et al. Pregnancy in patients with a porcine valve bioprosthesis. Am J Cardiol 1982;50:1051-1054
5. Valente M, Minarini M, Thiene G, et al. The pathology of Hancock Standard porcine valve prosthesis: A 20-year span of experience. J Cardiac Surg 1990;5:328-335
6. Bortolotti U, Guerra F, Magni A, et al. Emergency reoperation for primary tissue failure of porcine bioprostheses. Am J Cardiol 1987;60:920-921
7. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21
8. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-532
9. Shetty R, Pepin A, Charest A, et al. Expression of bone-regulatory proteins in human valve allografts. Heart 2006;92:1303-1308
10. Gong G, Ling Z, Seifter E, Factor SM, Frater RWM. Aldehyde tanning: The villain in bioprosthetic valve calcification. Eur J Cardiothorac Surg 1991;5:288-293
11. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171:1407-1418
12. Giddens DP, Yoganathan AP, Schoen FJ. Prosthetic cardiac valves. In: Harher KLA, Ratner BD, Didisheim L (ed.), Cardiovascular Biomaterials and Biocompatibility. Cardiovasc Pathol 1993;2(Suppl.3):167S-177S
13. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006;114:318-327
14. Koolbergen DR, Hazekamp MG, de Heer E, et al. The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 2002;124:689-697
15. Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 2006;27:1507-1518
16. Schoen FJ, Fernandez J, Gonzales-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: Emphasis on progressive structural deterioration. Circulation 1987;76:618-627
17. Thiene G, Bortolotti U, Valente M, et al. Mode of failure of the Hancock pericardial valve xenograft. Am J Cardiol 1989;63:129-133
18. Bortolotti U, Ius P, Theine G, et al. The Meadox-Gabbay pericardial xenograft: Failure of the unicusp principle. Ann Thorac Surg 1992;54:952-958
19. .Valente M, Laborde F, Thiene G, et al. Evaluation of Pericarbon valve prosthesis: In vitro, ultrastructural and animal studies. J Cardiac Surg 1989;4:79-88
20. Thiene G, Laborde F, Gallix P, Talenti E, Calabrese F, Piwnica A. Morphological survey of a new pericardial valve prosthesis (Pericarbon): Long-term animal experimental model. Eur J Cardiothorac Surg 1989;3:65-74
21. .Valente M, Ius P, Bortolotti U, Talenti E, Bottio T, Thiene G. Pathology of the Pericarbon bovine pericardial xenograft implanted in humans. J Heart Valve Dis 1998;7:180-189
22. Liao K, Siefter E, Hoffman D, Yellin EL, Frater RWM. Bovine pericardium versus porcine aortic valve: Comparison of tissue biological properties as prosthetic valves. Artif Organs 1992;16:361-365
23. Thiene G, Valente M. Calcification of valve bioprostheses: The cardiac surgeon's nightmare. Eur J Cardiothorac Surg 1994;8:476-477
24. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-329
25. Hoffmann D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RWM. Spontaneous host endothelia growth on bioprostheses. Influence of fixation. Circulation 1992;86:II75-II79
26. Jorge-Herrero E, Fernandez P, Escudero C, Garcia-Paez JM, Castillo-Olivares JL. Calcification of pericardial tissue pretreated with different amino-acids. Biomaterials 1996;17:571-575
27. Jorge-Herrero E, Fernandez P, De La Torre N, et al. Inhibition of the calcification of porcine valve tissue by selective lipid removal. Biomaterials 1994;15:815-820
28. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulphate: Preincubation and controlled release studies. J Biomed Mater Res 1993;27:1477-1484
29. Vyavahare N, Hirsch D, Lerner E, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-488
30. Vyavahare NR, Hirsch D, Lerner E, et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: Mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998;40:577-585
31. Cunanan CM, Cabiling CM, Dinh TT, et al. Tissue characterization and calcification potential of commercial bioprosthetic heart valves. Ann Thorac Surg 2001;71:S417-S421
32. .Valente M, Pettenazzo E, Thiene G, et al. Detoxified glutaraldehyde cross-linked pericardium: Tissue preservation and mineralization mitigation in a subcutaneous rat model. J Heart Valve Dis 1998;7:283-291
33. Pettenazzo E, Valente M, Thiene G. Octanediol treatment of glutaraldehyde fixed bovine pericardium: Evidence of anticalcification efficacy in the subcutaneous rat model. Eur J Cardiothorac Surg 2008;34:418-422
34. Deiwick M, Glasmacher B, Pettenazzo E, et al. Primary tissue failure of bioprostheses: New evidence from in vitro tests. Thorac Cardiovasc Surg 2001;49:78-83
35. Pettenazzo E, Deiwick M, Thiene G, et al. Dynamic in vitro calcification of bioprosthetic porcine valves: Evidence of apatite crystallization. J Thorac Cardiovasc Surg 2001;121:500-509
36. Jones M, Eidbo EE, Hilbert SL, Ferrans VJ, Clark RE. The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep. Am Soc Artif Intern Organs Trans 1988;34:1027-1030
37. Bodnar E. The New FDA Guidelines. J Heart Valve Dis 1994;3:226-227
38. Thiene G. Durability of valve bioprostheses and the need of careful examination of explants. Ann Thorac Surg 2006;82:2340-2341
39. Bortolotti U, Gallucci V, Casarotto D, Thiene G. Fibrous tissue overgrowth on Hancock mitral xenografts: A cause of late prosthetic stenosis. J Thorac Cardiovasc Surg 1979;27:316-318
40. Thiene G, Bortolotti U, Panizzon G, Milano A, Gallucci V. Pathological substrates of thrombus formation after heart valve replacement with the Hancock bioprosthesis. J Thorac Cardiovasc Surg 1980;80:414-423
41. Arbustini E, Bortolotti U, Valente M, et al. Cusp disruption by massive lipid infiltration. J Thorac Cardiovasc Surg 1982;84:738-743
42. .Valente M, Arbustini E, Bortolotti U, Talenti E, Thiene G, Gallucci V. Glutaraldehyde-preserved porcine bioprosthesis. Factors affecting performance as determined by pathologic studies. Chest 1983;83:607-611
43. .Valente M, Arbustini E, Bortolotti U, Talenti E, Thiene G. Perforation of muscle shelf of right coronary cusp causing acute regurgitation of porcine mitral xenograft. Am Heart J 1984;108:180-183
44. Thiene G, Bortolotti U, Talenti E, et al. Dissecting cuspal hematomas: A rare form of porcine bioprosthetic valve dysfunction. Arch Pathol Lab Med 1987;111:964-967
45. Valente M, Bortolotti U, Thiene G, et al. Post bending of the flexible stent in mitral Hancock bioprostheses. Eur J Cardiothorac Surg 1987;1:134-138
46. Valente M, Minarini M, Maizza AF, Bortolotti U, Thiene G. Heart valve bioprosthesis durability: A challenge to the new generation of porcine valves. Eur J Cardiothorac Surg 1992;6:S82-S90
47. Ius P, Valente M, Thiene G. Nonfatal stent fracture in porcine Wessex xenografts implanted in the mitral position. Am J Cardiol 1996;78:972-973
48. Bottio T, Valente M, Rizzoli G, et al. Commissural dehiscence: A rare and peculiar cause of porcine valve structural deterioration. J Thorac Cardiovasc Surg 2006;132:1017-1022
49. Bortolotti U, Thiene G, Milano A, Panizzon G, Valente M, Gallucci V. Pathological study of infective endocarditis on Hancock porcine bioprostheses. J Thorac Cardiovasc Surg 1981:81:934-942
50. Pettenazzo E, Thiene G, Gatti AM, et al. Is the tricuspid position suitable for testing replacement bioprosthetic valves in the sheep model? J Heart Valve Dis 2001;10:513-519
51. .Weber PA, Jouan J, Matsunaga A, et al. Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J Thorac Cardiovasc Surg 2006;132:1137-1143
52. Rizzoli G, Mirone S, Ius P, et al. Fifteen-year results with the Hancock II valve: A multicenter experience. J Thorac Cardiovasc Surg 2006;132:602-609
53. Bottio T, Thiene G, Pettenazzo E, et al. Hancock II bioprosthesis: A glance at the microscope in mid-long-term explants. J Thorac Cardiovasc Surg 2003;126:99-106
54. Shetty R, Pibarot P, Audet A, et al. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur J Clin Invest 2009;39:471-480